These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


309 related items for PubMed ID: 16341347

  • 1. Treatment with etanercept for patients with juvenile rheumatoid arthritis in Taiwan--a preliminary report.
    Liang TC, Yang YH, Lin YT, Chiang BL.
    J Microbiol Immunol Infect; 2005 Dec; 38(6):447-50. PubMed ID: 16341347
    [Abstract] [Full Text] [Related]

  • 2. Etanercept therapy in children with juvenile rheumatoid arthritis.
    Hung JJ, Huang JL.
    J Microbiol Immunol Infect; 2005 Dec; 38(6):444-6. PubMed ID: 16341346
    [Abstract] [Full Text] [Related]

  • 3. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.
    Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Lange M, Finck BK, Burge DJ, Pediatric Rheumatology Collaborative Study Group.
    Arthritis Rheum; 2003 Jan; 48(1):218-26. PubMed ID: 12528122
    [Abstract] [Full Text] [Related]

  • 4. Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis.
    Lovell DJ, Reiff A, Jones OY, Schneider R, Nocton J, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore JB, White B, Giannini EH, Pediatric Rheumatology Collaborative Study Group.
    Arthritis Rheum; 2006 Jun; 54(6):1987-94. PubMed ID: 16732547
    [Abstract] [Full Text] [Related]

  • 5. Prolonged efficacy of etanercept in refractory enthesitis-related arthritis.
    Henrickson M, Reiff A.
    J Rheumatol; 2004 Oct; 31(10):2055-61. PubMed ID: 15468375
    [Abstract] [Full Text] [Related]

  • 6. Taiwan experience with etanercept in juvenile rheumatoid arthritis.
    Lai JH.
    J Microbiol Immunol Infect; 2005 Dec; 38(6):451-4. PubMed ID: 16341348
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
    Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, Sibilia J, Koné-Paut I, Gandon-Laloum S, LeBideau M, Bader-Meunier B, Mouy R, Debré M, Landais P, Prieur AM.
    Arthritis Rheum; 2003 Apr; 48(4):1093-101. PubMed ID: 12687553
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis.
    Horneff G, Ebert A, Fitter S, Minden K, Foeldvari I, Kümmerle-Deschner J, Thon A, Girschick HJ, Weller F, Huppertz HI.
    Rheumatology (Oxford); 2009 Aug; 48(8):916-9. PubMed ID: 19483091
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis.
    Takei S, Groh D, Bernstein B, Shaham B, Gallagher K, Reiff A.
    J Rheumatol; 2001 Jul; 28(7):1677-80. PubMed ID: 11469478
    [Abstract] [Full Text] [Related]

  • 10. Etanercept for the treatment of psoriasis: combination therapy with other modalities.
    Strober BE, Clarke S.
    J Drugs Dermatol; 2004 Jul; 3(3):270-2. PubMed ID: 15176161
    [Abstract] [Full Text] [Related]

  • 11. Etanercept Immunex.
    Yung RL.
    Curr Opin Investig Drugs; 2001 Feb; 2(2):216-21. PubMed ID: 11816834
    [Abstract] [Full Text] [Related]

  • 12. Clinical response to etanercept in polyarticular course juvenile rheumatoid arthritis.
    Kietz DA, Pepmueller PH, Moore TL.
    J Rheumatol; 2001 Feb; 28(2):360-2. PubMed ID: 11246677
    [Abstract] [Full Text] [Related]

  • 13. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.
    Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore J, Finck BK.
    N Engl J Med; 2000 Mar 16; 342(11):763-9. PubMed ID: 10717011
    [Abstract] [Full Text] [Related]

  • 14. Etanercept therapy in children with treatment-resistant uveitis.
    Reiff A, Takei S, Sadeghi S, Stout A, Shaham B, Bernstein B, Gallagher K, Stout T.
    Arthritis Rheum; 2001 Jun 16; 44(6):1411-5. PubMed ID: 11407702
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis.
    Lovell DJ, Reiff A, Ilowite NT, Wallace CA, Chon Y, Lin SL, Baumgartner SW, Giannini EH, Pediatric Rheumatology Collaborative Study Group.
    Arthritis Rheum; 2008 May 16; 58(5):1496-504. PubMed ID: 18438876
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
    Horneff G, De Bock F, Foeldvari I, Girschick HJ, Michels H, Moebius D, Schmeling H, German and Austrian Paediatric Rheumatology Collaborative Study Group.
    Ann Rheum Dis; 2009 Apr 16; 68(4):519-25. PubMed ID: 18413440
    [Abstract] [Full Text] [Related]

  • 17. Etanercept (Enbrel) -- an update.
    Goffe B.
    Skin Therapy Lett; 2009 Apr 16; 9(10):1-4, 9. PubMed ID: 15657632
    [Abstract] [Full Text] [Related]

  • 18. Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein.
    Zhou H.
    J Clin Pharmacol; 2005 May 16; 45(5):490-7. PubMed ID: 15831771
    [Abstract] [Full Text] [Related]

  • 19. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
    Prince FH, Twilt M, ten Cate R, van Rossum MA, Armbrust W, Hoppenreijs EP, van Santen-Hoeufft M, Koopman-Keemink Y, Wulffraat NM, van Suijlekom-Smit LW.
    Ann Rheum Dis; 2009 May 16; 68(5):635-41. PubMed ID: 18413443
    [Abstract] [Full Text] [Related]

  • 20. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis.
    Ramanan AV, Schneider R.
    J Rheumatol; 2003 Feb 16; 30(2):401-3. PubMed ID: 12563702
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.